Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

veradermics.com

Veradermics Newsroom

Get the latest updates from Veradermics Newsroom directly as they happen.

Follow now < 10 followers

Latest posts

Last updated 17 days ago

December 11, 2024

17 days ago

December 11, 2024Veradermics Raises $75 Million in Series B Financing and Initiates...

November 29, 2023

17 days ago

November 29, 2023Veradermics CEO Reid Waldman is selected as a Forbes 30...

November 7, 2023

17 days ago

November 7, 2023Veradermics Doses First Patient in a First-in-Human Clinical Trial for...

Veradermics CEO Reid Waldman is selected as a Forbes 30 Under 30 for 2024

2 months ago

Veradermics CEO Reid Waldman is selected as a Forbes 30 Under 30...

Veradermics Inc. Secures Licensing of First-in-Class Antiviral Targeting the Treatment of Molluscum Contagiosum and other Poxviruses

2 months ago

Veradermics Inc. Secures Licensing of First-in-Class Antiviral Targeting the Treatment of Molluscum...

This Startup Raised $20.7 Million To Develop A Kid-Friendly Wart Treatment

2 months ago

ForbesThis Startup Raised $20.7 Million To Develop A Kid-Friendly Wart TreatmentRead All

Why Are We Still Killing Warts the Way We Did in the 1950s? Rethinking a pesky condition.

2 months ago

SlateWhy Are We Still Killing Warts the Way We Did in the...

Kansas City dermatologist launches startup to address common childhood ailment

2 months ago

Business JournalKansas City dermatologist launches startup to address common childhood ailmentRead All

Veradermics Doses First Patient in a First-in-Human Clinical Trial for VDPHL for the Treatment of Pattern Hair Loss (Androgenetic Alopecia)

2 months ago

November 7, 2023Veradermics Doses First Patient in a First-in-Human Clinical Trial for...

Veradermics Doses First Patient in Phase 2 Clinical Trial for VDMN for the Treatment of Common Warts

2 months ago

March 24, 2023Veradermics Doses First Patient in Phase 2 Clinical Trial for...